{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T07:28:43Z","timestamp":1792394923574,"version":"4.4.0"},"reference-count":100,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2010,4,1]],"date-time":"2010-04-01T00:00:00Z","timestamp":1270080000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2010,4]]},"DOI":"10.1016\/j.autrev.2009.12.004","type":"journal-article","created":{"date-parts":[[2009,12,17]],"date-time":"2009-12-17T15:11:11Z","timestamp":1261062671000},"page":"441-448","source":"Crossref","is-referenced-by-count":96,"title":["Kawasaki disease: Aetiopathogenesis and therapeutic utility of intravenous immunoglobulin"],"prefix":"10.1016","volume":"9","author":[{"given":"Caroline","family":"Galeotti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jagedeesh","family":"Bayry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Kone-Paut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srinivas V.","family":"Kaveri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2009.12.004_bib1","first-page":"178","article-title":"Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children","volume":"16","author":"Kawasaki","year":"1967","journal-title":"Jpn J Allergy"},{"key":"10.1016\/j.autrev.2009.12.004_bib2","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1542\/peds.54.3.277","article-title":"Myocardial infarction due to coronary thromboarteritis, following acute febrile mucocutaneous lymph node syndrome (MLNS) in an infant","volume":"54","author":"Yanagisawa","year":"1974","journal-title":"Pediatrics"},{"key":"10.1016\/j.autrev.2009.12.004_bib3","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/S0022-3476(75)80220-4","article-title":"Coronary aneurysms in infants and young children with acute febrile mucocutaneous lymph node syndrome","volume":"86","author":"Kato","year":"1975","journal-title":"J Pediatr"},{"key":"10.1016\/j.autrev.2009.12.004_bib4","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s00246-002-0216-2","article-title":"Immunoglobulin failure and retreatment in Kawasaki disease","volume":"24","author":"Durongpisitkul","year":"2003","journal-title":"Pediatr Cardiol"},{"key":"10.1016\/j.autrev.2009.12.004_bib5","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1542\/peds.2004-2182","article-title":"Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association","volume":"114","author":"Newburger","year":"2004","journal-title":"Pediatrics"},{"key":"10.1016\/j.autrev.2009.12.004_bib6","first-page":"218","article-title":"Pathological features of Kawasaki disease (mucocutaneous lymph node syndrome)","volume":"1","author":"Landing","year":"1987","journal-title":"Am J Cardiovasc Pathol"},{"key":"10.1016\/j.autrev.2009.12.004_bib7","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1161\/01.CIR.94.6.1379","article-title":"Long-term consequences of Kawasaki disease. A 10- to 21-year follow-up study of 594 patients","volume":"94","author":"Kato","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.autrev.2009.12.004_bib8","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0022-3476(87)80503-6","article-title":"Incomplete Kawasaki disease with coronary artery involvement","volume":"110","author":"Rowley","year":"1987","journal-title":"J Pediatr"},{"key":"10.1016\/j.autrev.2009.12.004_bib9","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1097\/00006454-200206000-00015","article-title":"Incomplete (atypical) Kawasaki disease","volume":"21","author":"Rowley","year":"2002","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.autrev.2009.12.004_bib10","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1111\/j.1442-200X.1991.tb02612.x","article-title":"Intravenous gamma-globulin treatment in Kawasaki disease","volume":"33","author":"Harada","year":"1991","journal-title":"Acta Paediatr Jpn"},{"key":"10.1016\/j.autrev.2009.12.004_bib11","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/S0022-3476(05)83493-6","article-title":"Immunoglobulin allotypic markers in Kawasaki disease","volume":"122","author":"Shulman","year":"1993","journal-title":"J Pediatr"},{"key":"10.1016\/j.autrev.2009.12.004_bib12","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1097\/MOP.0b013e328012720f","article-title":"New developments in the search for the etiologic agent of Kawasaki disease","volume":"19","author":"Rowley","year":"2007","journal-title":"Curr Opin Pediatr"},{"key":"10.1016\/j.autrev.2009.12.004_bib13","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/S1568-9972(03)00032-6","article-title":"An update on Kawasaki disease","volume":"2","author":"Cimaz","year":"2003","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2009.12.004_bib14","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1080\/08916930802613210","article-title":"The infectious etiology of vasculitis","volume":"42","author":"Lidar","year":"2009","journal-title":"Autoimmunity"},{"key":"10.1016\/j.autrev.2009.12.004_bib15","doi-asserted-by":"crossref","first-page":"167","DOI":"10.2188\/jea.JE2008001","article-title":"Epidemiologic features of Kawasaki disease in Japan: results from the nationwide survey in 2005\u20132006","volume":"18","author":"Nakamura","year":"2008","journal-title":"J Epidemiol"},{"key":"10.1016\/j.autrev.2009.12.004_bib16","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S0140-6736(04)16814-1","article-title":"Kawasaki syndrome","volume":"364","author":"Burns","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.autrev.2009.12.004_bib17","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1399-0039.1992.tb01915.x","article-title":"The HLA class II region and susceptibility to Kawasaki disease","volume":"39","author":"Fildes","year":"1992","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.autrev.2009.12.004_bib18","first-page":"537","article-title":"Genetic analysis of Kawasaki syndrome","volume":"39","author":"Harada","year":"1986","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.autrev.2009.12.004_bib19","doi-asserted-by":"crossref","first-page":"e1000319","DOI":"10.1371\/journal.pgen.1000319","article-title":"A genome-wide association study identifies novel and functionally related susceptibility Loci for Kawasaki disease","volume":"5","author":"Burgner","year":"2009","journal-title":"PLoS Genet"},{"key":"10.1016\/j.autrev.2009.12.004_bib20","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1038\/sj.gene.6364225","article-title":"Family-based association analysis implicates IL-4 in susceptibility to Kawasaki disease","volume":"6","author":"Burns","year":"2005","journal-title":"Genes Immun"},{"key":"10.1016\/j.autrev.2009.12.004_bib21","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1086\/430953","article-title":"Genetic variations in the receptor-ligand pair CCR5 and CCL3L1 are important determinants of susceptibility to Kawasaki disease","volume":"192","author":"Burns","year":"2005","journal-title":"J Infect Dis"},{"issue":"8516","key":"10.1016\/j.autrev.2009.12.004_bib22","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1016\/S0140-6736(86)90541-6","article-title":"Nationwide epidemic of Kawasaki disease in Japan during winter of 1985\u201386","volume":"2","author":"Yanagawa","year":"1986","journal-title":"Lancet"},{"key":"10.1016\/j.autrev.2009.12.004_bib23","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1038\/nrmicro1853","article-title":"Searching for the cause of Kawasaki disease\u2014cytoplasmic inclusion bodies provide new insight","volume":"6","author":"Rowley","year":"2008","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.autrev.2009.12.004_bib24","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1542\/peds.66.4.633","article-title":"Urine mercury levels in Kawasaki disease","volume":"66","author":"Orlowski","year":"1980","journal-title":"Pediatrics"},{"issue":"7819","key":"10.1016\/j.autrev.2009.12.004_bib25","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/S0140-6736(73)91975-2","article-title":"Rickettsia-like bodies in infantile acute febrile mucocutaneous lymph-node syndrome","volume":"2","author":"Hamashima","year":"1973","journal-title":"Lancet"},{"issue":"8364","key":"10.1016\/j.autrev.2009.12.004_bib26","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1016\/S0140-6736(83)90921-2","article-title":"Variant strain of Propionibacterium acnes: a clue to the aetiology of Kawasaki disease","volume":"2","author":"Kato","year":"1983","journal-title":"Lancet"},{"issue":"8298","key":"10.1016\/j.autrev.2009.12.004_bib27","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/S0140-6736(82)90660-2","article-title":"Kawasaki syndrome: association with the application of rug shampoo","volume":"2","author":"Patriarca","year":"1982","journal-title":"Lancet"},{"key":"10.1016\/j.autrev.2009.12.004_bib28","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/S0022-3476(78)81125-1","article-title":"Leptospiral antibody and MLNS","volume":"93","author":"Ohtaki","year":"1978","journal-title":"J Pediatr"},{"key":"10.1016\/j.autrev.2009.12.004_bib29","first-page":"571","article-title":"Variant Streptococcus sanguis as an etiological agent of Kawasaki disease Japanese gamma globulin trials for Kawasaki disease","volume":"250","author":"Shinomiya","year":"1987","journal-title":"Prog Clin Biol Res"},{"key":"10.1016\/j.autrev.2009.12.004_bib30","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1203\/00006450-199105010-00001","article-title":"Failure to confirm the presence of a retrovirus in cultured lymphocytes from patients with Kawasaki syndrome","volume":"29","author":"Rowley","year":"1991","journal-title":"Pediatr Res"},{"issue":"8506","key":"10.1016\/j.autrev.2009.12.004_bib31","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/S0140-6736(86)90115-7","article-title":"Does Kawasaki disease have a retroviral aetiology?","volume":"2","author":"Shulman","year":"1986","journal-title":"Lancet"},{"key":"10.1016\/j.autrev.2009.12.004_bib32","doi-asserted-by":"crossref","first-page":"e53","DOI":"10.1086\/432578","article-title":"Primary cytomegalovirus infection, atypical Kawasaki disease, and coronary aneurysms in 2 infants","volume":"41","author":"Catalano-Pons","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.autrev.2009.12.004_bib33","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1086\/509509","article-title":"Blinded case-control study of the relationship between human coronavirus NL63 and Kawasaki syndrome","volume":"194","author":"Dominguez","year":"2006","journal-title":"J Infect Dis"},{"key":"10.1016\/j.autrev.2009.12.004_bib34","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1086\/428291","article-title":"Association between a novel human coronavirus and Kawasaki disease","volume":"191","author":"Esper","year":"2005","journal-title":"J Infect Dis"},{"key":"10.1016\/j.autrev.2009.12.004_bib35","doi-asserted-by":"crossref","first-page":"4066","DOI":"10.1073\/pnas.89.9.4066","article-title":"Selective expansion of T cells expressing T-cell receptor variable regions V beta 2 and V beta 8 in Kawasaki disease","volume":"89","author":"Abe","year":"1992","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.autrev.2009.12.004_bib36","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1084\/jem.177.3.791","article-title":"Characterization of T cell repertoire changes in acute Kawasaki disease","volume":"177","author":"Abe","year":"1993","journal-title":"J Exp Med"},{"key":"10.1016\/j.autrev.2009.12.004_bib37","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1086\/422648","article-title":"Detection of antigen in bronchial epithelium and macrophages in acute Kawasaki disease by use of synthetic antibody","volume":"190","author":"Rowley","year":"2004","journal-title":"J Infect Dis"},{"key":"10.1016\/j.autrev.2009.12.004_bib38","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1046\/j.1365-2249.2002.02000.x","article-title":"The role of anti-endothelial cell antibodies in Kawasaki disease\u2013in vitro and in vivo studies","volume":"130","author":"Grunebaum","year":"2002","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2009.12.004_bib39","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1159\/000237447","article-title":"High levels of circulating interleukin-4 and interleukin-10 in Kawasaki disease","volume":"112","author":"Hirao","year":"1997","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.autrev.2009.12.004_bib40","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/0090-1229(88)90088-8","article-title":"Peripheral blood monocyte\/macrophages and serum tumor necrosis factor in Kawasaki disease","volume":"48","author":"Furukawa","year":"1988","journal-title":"Clin Immunol Immunopathol"},{"key":"10.1016\/j.autrev.2009.12.004_bib41","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/S0022-3476(05)80343-9","article-title":"Serial changes of serum interleukin-6, interleukin-8, and tumor necrosis factor alpha among patients with Kawasaki disease","volume":"121","author":"Lin","year":"1992","journal-title":"J Pediatr"},{"issue":"8675","key":"10.1016\/j.autrev.2009.12.004_bib42","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1016\/S0140-6736(89)91910-7","article-title":"Endothelial cell activation and high interleukin-1 secretion in the pathogenesis of acute Kawasaki disease","volume":"2","author":"Leung","year":"1989","journal-title":"Lancet"},{"key":"10.1016\/j.autrev.2009.12.004_bib43","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1006\/jaut.1993.1021","article-title":"The role of the endothelium in systemic vasculitis","volume":"6","author":"Savage","year":"1993","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2009.12.004_bib44","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1177\/0961203309346654","article-title":"Pathogenic role of anti-endothelial cell antibodies in autoimmune rheumatic diseases","volume":"18","author":"Domiciano","year":"2009","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2009.12.004_bib45","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1172\/JCI112454","article-title":"Immunoglobulin M antibodies present in the acute phase of Kawasaki syndrome lyse cultured vascular endothelial cells stimulated by gamma interferon","volume":"77","author":"Leung","year":"1986","journal-title":"J Clin Invest"},{"key":"10.1016\/j.autrev.2009.12.004_bib46","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1084\/jem.164.6.1958","article-title":"Two monokines, interleukin 1 and tumor necrosis factor, render cultured vascular endothelial cells susceptible to lysis by antibodies circulating during Kawasaki syndrome","volume":"164","author":"Leung","year":"1986","journal-title":"J Exp Med"},{"key":"10.1016\/j.autrev.2009.12.004_bib47","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1203\/01.PDR.0000113464.93042.A4","article-title":"Enhanced iNOS expression in leukocytes and circulating endothelial cells is associated with the progression of coronary artery lesions in acute Kawasaki disease","volume":"55","author":"Yu","year":"2004","journal-title":"Pediatr Res"},{"key":"10.1016\/j.autrev.2009.12.004_bib48","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1007\/s00431-008-0872-1","article-title":"Increased nitric oxide production by neutrophils in early stage of Kawasaki disease","volume":"168","author":"Yoshimura","year":"2009","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.autrev.2009.12.004_bib49","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/j.1365-2249.2007.03326.x","article-title":"Increased CD11b expression on polymorphonuclear leucocytes and cytokine profiles in patients with Kawasaki disease","volume":"148","author":"Kobayashi","year":"2007","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2009.12.004_bib50","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1046\/j.1442-200x.2001.01362.x","article-title":"Serum levels of neutrophil activation cytokines in Kawasaki disease","volume":"43","author":"Suzuki","year":"2001","journal-title":"Pediatr Int"},{"key":"10.1016\/j.autrev.2009.12.004_bib51","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1086\/315832","article-title":"IgA plasma cell infiltration of proximal respiratory tract, pancreas, kidney, and coronary artery in acute Kawasaki disease","volume":"182","author":"Rowley","year":"2000","journal-title":"J Infect Dis"},{"key":"10.1016\/j.autrev.2009.12.004_bib52","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.cell.2008.05.009","article-title":"Regulatory T cells and immune tolerance","volume":"133","author":"Sakaguchi","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.autrev.2009.12.004_bib53","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.2353\/ajpath.2009.080987","article-title":"Surveillance of antigen-presenting cells by CD4+ CD25+ regulatory T cells in autoimmunity: immunopathogenesis and therapeutic implications","volume":"174","author":"Andre","year":"2009","journal-title":"Am J Pathol"},{"key":"10.1016\/j.autrev.2009.12.004_bib54","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1038\/nrrheum.2009.77","article-title":"Autoimmunity: CTLA-4: a key protein in autoimmunity","volume":"5","author":"Bayry","year":"2009","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.autrev.2009.12.004_bib55","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/j.1600-065X.2008.00637.x","article-title":"Human regulatory T cells: role in autoimmune disease and therapeutic opportunities","volume":"223","author":"Brusko","year":"2008","journal-title":"Immunol Rev"},{"key":"10.1016\/j.autrev.2009.12.004_bib56","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.jpeds.2004.05.048","article-title":"CD25+CD4+ regulatory T cells in patients with Kawasaki disease","volume":"145","author":"Furuno","year":"2004","journal-title":"J Pediatr"},{"key":"10.1016\/j.autrev.2009.12.004_bib57","doi-asserted-by":"crossref","first-page":"481","DOI":"10.4049\/jimmunol.159.1.481","article-title":"Clonal expansion of CD8+ T cells in Kawasaki disease","volume":"159","author":"Choi","year":"1997","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2009.12.004_bib58","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1056\/NEJM199106063242305","article-title":"A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndrome","volume":"324","author":"Newburger","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2009.12.004_bib59","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/ncprheum0481","article-title":"Monoclonal antibody and intravenous immunoglobulin therapy for rheumatic diseases: rationale and mechanisms of action","volume":"3","author":"Bayry","year":"2007","journal-title":"Nat Clin Pract Rheumatol"},{"key":"10.1016\/j.autrev.2009.12.004_bib60","first-page":"CD004000","article-title":"Intravenous immunoglobulin for the treatment of Kawasaki disease in children","author":"Oates-Whitehead","year":"2003","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.autrev.2009.12.004_bib61","first-page":"CD004175","article-title":"Salicylate for the treatment of Kawasaki disease in children","author":"Baumer","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.autrev.2009.12.004_bib62","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/j.jaci.2008.09.011","article-title":"Elevated granulocyte colony-stimulating factor levels predict treatment failure in patients with Kawasaki disease","volume":"122","author":"Abe","year":"2008","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.autrev.2009.12.004_bib63","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jpeds.2006.03.050","article-title":"Prediction of resistance to intravenous immunoglobulin treatment in patients with Kawasaki disease","volume":"149","author":"Egami","year":"2006","journal-title":"J Pediatr"},{"key":"10.1016\/j.autrev.2009.12.004_bib64","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1203\/PDR.0b013e3181baa3c2","article-title":"Clinical score and transcript abundance patterns identify Kawasaki disease patients who may benefit from addition of methylprednisolone","volume":"66","author":"Ogata","year":"2009","journal-title":"Pediatr Res"},{"key":"10.1016\/j.autrev.2009.12.004_bib65","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.autrev.2007.03.009","article-title":"Potential target of infliximab in autoimmune and inflammatory diseases","volume":"6","author":"Atzeni","year":"2007","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2009.12.004_bib66","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/S0022-3476(96)70447-X","article-title":"Treatment of immune globulin-resistant Kawasaki disease with pulsed doses of corticosteroids","volume":"128","author":"Wright","year":"1996","journal-title":"J Pediatr"},{"key":"10.1016\/j.autrev.2009.12.004_bib67","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1046\/j.1442-200x.2001.01373.x","article-title":"Re-treatment for immune globulin-resistant Kawasaki disease: a comparative study of additional immune globulin and steroid pulse therapy","volume":"43","author":"Hashino","year":"2001","journal-title":"Pediatr Int"},{"key":"10.1016\/j.autrev.2009.12.004_bib68","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1136\/adc.2007.126144","article-title":"Effects of steroid pulse therapy on immunoglobulin-resistant Kawasaki disease","volume":"93","author":"Furukawa","year":"2008","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.autrev.2009.12.004_bib69","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.jpeds.2004.12.022","article-title":"Infliximab treatment for refractory Kawasaki syndrome","volume":"146","author":"Burns","year":"2005","journal-title":"J Pediatr"},{"key":"10.1016\/j.autrev.2009.12.004_bib70","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.jpeds.2008.06.011","article-title":"Infliximab treatment of intravenous immunoglobulin-resistant Kawasaki disease","volume":"153","author":"Burns","year":"2008","journal-title":"J Pediatr"},{"key":"10.1016\/j.autrev.2009.12.004_bib71","doi-asserted-by":"crossref","first-page":"E4","DOI":"10.1542\/peds.109.1.e4","article-title":"Does Abciximab enhance regression of coronary aneurysms resulting from Kawasaki disease?","volume":"109","author":"Williams","year":"2002","journal-title":"Pediatrics"},{"key":"10.1016\/j.autrev.2009.12.004_bib72","doi-asserted-by":"crossref","first-page":"714","DOI":"10.3349\/ymj.2008.49.5.714","article-title":"Low-dose methotrexate therapy for intravenous immunoglobulin-resistant Kawasaki disease","volume":"49","author":"Lee","year":"2008","journal-title":"Yonsei Med J"},{"key":"10.1016\/j.autrev.2009.12.004_bib73","doi-asserted-by":"crossref","first-page":"E78","DOI":"10.1542\/peds.105.6.e78","article-title":"Initial intravenous gammaglobulin treatment failure in Kawasaki disease","volume":"105","author":"Wallace","year":"2000","journal-title":"Pediatrics"},{"key":"10.1016\/j.autrev.2009.12.004_bib74","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1542\/peds.112.4.986","article-title":"Longstanding obliterative panarteritis in Kawasaki disease: lack of cyclosporin A effect","volume":"112","author":"Kuijpers","year":"2003","journal-title":"Pediatrics"},{"key":"10.1016\/j.autrev.2009.12.004_bib75","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s00431-003-1267-y","article-title":"Plasma exchange for refractory Kawasaki disease","volume":"163","author":"Imagawa","year":"2004","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.autrev.2009.12.004_bib76","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1056\/NEJMra993360","article-title":"Immunomodulation of autoimmune and inflammatory diseases with intravenous immune globulin","volume":"345","author":"Kazatchkine","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2009.12.004_bib77","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.autrev.2008.04.012","article-title":"What is the contents of the magic draft IVIg?","volume":"7","author":"Seite","year":"2008","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2009.12.004_bib78","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.autrev.2008.04.011","article-title":"Role of natural antibodies in immune homeostasis: IVIg perspective","volume":"7","author":"Vani","year":"2008","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2009.12.004_bib79","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.autrev.2006.08.011","article-title":"Safety of intravenous immunoglobulin (IVIG) therapy","volume":"6","author":"Katz","year":"2007","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2009.12.004_bib80","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.it.2008.08.004","article-title":"Modulation of the cellular immune system by intravenous immunoglobulin","volume":"29","author":"Tha-In","year":"2008","journal-title":"Trends Immunol"},{"key":"10.1016\/j.autrev.2009.12.004_bib81","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1080\/08916930902785363","article-title":"Intravenous immunoglobulin therapy for autoimmune diseases","volume":"42","author":"Arnson","year":"2009","journal-title":"Autoimmunity"},{"key":"10.1016\/j.autrev.2009.12.004_bib82","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.autrev.2008.04.001","article-title":"Intravenous immunoglobulin\u2013indications and mechanisms in cardiovascular diseases","volume":"7","author":"Udi","year":"2008","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2009.12.004_bib83","article-title":"Evidence for the use of intravenous immunoglobulins\u2014a review of the literature","author":"Kivity","year":"2009","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.autrev.2009.12.004_bib84","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/ncpneuro0376","article-title":"Drug Insight: the use of intravenous immunoglobulin in neurology\u2014therapeutic considerations and practical issues","volume":"3","author":"Gold","year":"2007","journal-title":"Nat Clin Pract Neurol"},{"issue":"8411","key":"10.1016\/j.autrev.2009.12.004_bib85","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/S0140-6736(84)91504-6","article-title":"High-dose intravenous gammaglobulin for Kawasaki disease","volume":"2","author":"Furusho","year":"1984","journal-title":"Lancet"},{"key":"10.1016\/j.autrev.2009.12.004_bib86","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1056\/NEJMcibr0803649","article-title":"The antiinflammatory IgG","volume":"359","author":"Kaveri","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2009.12.004_bib87","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1146\/annurev.immunol.26.021607.090232","article-title":"Anti-inflammatory actions of intravenous immunoglobulin","volume":"26","author":"Nimmerjahn","year":"2008","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.autrev.2009.12.004_bib88","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.autrev.2008.04.014","article-title":"Modulation of human dendritic cell maturation and function by natural IgG antibodies","volume":"7","author":"Elluru","year":"2008","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2009.12.004_bib89","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.autrev.2008.03.015","article-title":"Natural anti-Siglec autoantibodies mediate potential immunoregulatory mechanisms: implications for the clinical use of intravenous immunoglobulins (IVIg)","volume":"7","author":"von Gunten","year":"2008","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2009.12.004_bib90","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/S0002-9440(10)65670-2","article-title":"Modulation of endothelial cell function by normal polyspecific human intravenous immunoglobulins: a possible mechanism of action in vascular diseases","volume":"153","author":"Xu","year":"1998","journal-title":"Am J Pathol"},{"key":"10.1016\/j.autrev.2009.12.004_bib91","doi-asserted-by":"crossref","first-page":"3624","DOI":"10.1182\/blood.V93.11.3624","article-title":"Inhibition of cell adhesion by antibodies to Arg-Gly-Asp (RGD) in normal immunoglobulin for therapeutic use (intravenous immunoglobulin, IVIg)","volume":"93","author":"Vassilev","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2009.12.004_bib92","first-page":"1798","article-title":"Nerve growth factor circulating levels are increased in Kawasaki disease: correlation with disease activity and reduced angiotensin converting enzyme levels","volume":"23","author":"Falcini","year":"1996","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2009.12.004_bib93","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jaut.2006.11.005","article-title":"Biologically active anti-nerve growth factor antibodies in commercial intravenous gammaglobulin","volume":"28","author":"Warrington","year":"2007","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2009.12.004_bib94","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1023\/A:1011039216251","article-title":"Cytokine modulation with immune gamma-globulin in peripheral blood of normal children and its implications in Kawasaki disease treatment","volume":"21","author":"Gupta","year":"2001","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.autrev.2009.12.004_bib95","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1002\/art.24660","article-title":"Intravenous immunoglobulin and salicylate differentially modulate pathogenic processes leading to vascular damage in a model of Kawasaki disease","volume":"60","author":"Lau","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2009.12.004_bib96","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1007\/s00210-004-0877-x","article-title":"Intravenous immunoglobulin inhibits NF-kappaB activation and affects Fcgamma receptor expression in monocytes\/macrophages","volume":"369","author":"Ichiyama","year":"2004","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1016\/j.autrev.2009.12.004_bib97","doi-asserted-by":"crossref","first-page":"5837","DOI":"10.4049\/jimmunol.174.9.5837","article-title":"Gene expression profiling of the effect of high-dose intravenous Ig in patients with Kawasaki disease","volume":"174","author":"Abe","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2009.12.004_bib98","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1093\/rheumatology\/keh488","article-title":"Intravenous immunoglobulin does not increase FcgammaRIIB expression on monocytes\/macrophages during acute Kawasaki disease","volume":"44","author":"Ichiyama","year":"2005","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2009.12.004_bib99","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1253\/circj.CJ-07-0635","article-title":"IVIG reduced vascular oxidative stress in patients with Kawasaki disease","volume":"73","author":"Takatsuki","year":"2009","journal-title":"Circ J"},{"key":"10.1016\/j.autrev.2009.12.004_bib100","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1172\/JCI112835","article-title":"Reversal of lymphocyte activation in vivo in the Kawasaki syndrome by intravenous gammaglobulin","volume":"79","author":"Leung","year":"1987","journal-title":"J Clin Invest"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997209002031?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997209002031?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,3,18]],"date-time":"2024-03-18T08:35:38Z","timestamp":1710750938000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997209002031"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4]]},"references-count":100,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,4]]}},"alternative-id":["S1568997209002031"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2009.12.004","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2010,4]]}}}